October 13, 2016
Theradiag: Revenue growth at end September 2016 +31%
THERADIAG a company specializing in in vitro diagnostics and theranostics, has reported its consolidated revenues for the 3rd quarter of 2016.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
October 13, 2016
STENTYS sees revenue up 26%over the first 9 months
STENTYS a medical technology company today announced its revenue for the third quarter and first 9 months to September 30, 2016.
October 13, 2016
Allergan’s BELKYRA Receives Marketing Authorisation In Sweden
Allergan announced that Sweden has received the Marketing Authorisation for BELKYRA (deoxycholic acid) after being granted approval by the Swedish Medical Products Agency (MPA).
October 13, 2016
SpineGuard Reports €1.7M Revenue for 3Q 2016, and 9 Months Growth of 15%
SpineGuard announced today that its third quarter revenue grew to €1.7 million, a 2% increase compared with 3Q 2015.
October 13, 2016
Adocia Announces Third Quarter 2016 Financial Results
Adocia a clinical stage biopharmaceutical company announced today third quarter revenue and net cash position ending September 30,2016.
October 13, 2016
Mauna Kea Technologies: Study of Cellvizio for Pediatric Cardiac Surgery
Mauna Kea Technologies inventor of Cellvizio, the multidisciplinary confocal laser endomicroscopy platform, announced today the launch of a ground-breaking new clinical study led by researchers at the University of Utah School of Medicine and Harvard Medical School called: “Evaluation of Fiberoptic Confocal Microscopy for Pediatric Cardiac Surgery.”
October 12, 2016
Bayer closed syndication of USD 56.9 billion acquisition facilities
Bayer has announced that the acquisition facilities of USD 56.9 billion that Bayer had agreed with five underwriter banks (BofA Merrill Lynch, Credit Suisse, Goldman Sachs, HSBC and JP Morgan) prior to announcement of the Monsanto acquisition has now been successfully syndicated within the group of Bayer’s core relationship banks.
October 12, 2016
October 12 – World Arthritis Day
Arthritis is very common but is not well understood. Actually, “arthritis” is not a single disease; it is an informal way of referring to joint pain or joint disease.
October 12, 2016
Pharmaceutical daily wishes you happy and healthy holidays!!!
Pharmaceutical daily brings daily pharmaceutical news from all around the world. We scoop for information about clinical research, new products in…
October 12, 2016
Said Darwazah, Chairman and CEO of Hikma, awarded Global Generics “Leader of the Year”
Hikma Pharmaceuticals has announced that Said Darwazah, Chairman and Chief Executive Officer of Hikma, received the “Leader of the Year Award” at the Global Generics and Biosimilars Awards held in Barcelona on 4 October 2016.